Søs Neergaard‐Petersen

The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease

Søs Neergaard‐Petersen, Anne‐Mette Hvas, Steen Dalby Kristensen et al. · Thrombosis and Haemostasis · 2014 · 59 citations

Medicine, Cardiology, Internal Medicine +17

Determinants of Reduced Antiplatelet Effect of Aspirin in Patients with Stable Coronary Artery Disease

Sanne Bøjet Larsen, Erik Lerkevang Grove, Søs Neergaard‐Petersen et al. · PLoS ONE · 2015 · 51 citations · Full text

Medicine, Pharmacology, Cardiovascular Pharmacotherapy +7

Fibrin Clot Structure and Platelet Aggregation in Patients with Aspirin Treatment Failure

Søs Neergaard‐Petersen, Ramzi Ajjan, Anne‐Mette Hvas et al. · PLoS ONE · 2013 · 40 citations · Full text

Medicine, Cardiology, Pharmacology +17

The activation peptide cleft exposed by thrombin cleavage of FXIII-A2 contains a recognition site for the fibrinogen α chain

Kerrie A. Smith, Richard J. Pease, Craig A. Avery et al. · Blood · 2013 · 34 citations

Life Sciences, Biochemistry, Molecular Biology +14

Coronary artery disease-associated genetic variants and biomarkers of inflammation

Morten Krogh Christiansen, Sanne Bøjet Larsen, Mette Nyegaard et al. · PLoS ONE · 2017 · 33 citations · Full text

Medicine, Cardiology, Genetics +17